- Home
- REED vs ALGS Comparison
REED vs ALGS Comparison
Compare REED & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REED | ALGS |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8M | 37.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | REED | ALGS |
|---|---|---|
| Price | $3.58 | $6.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 9.9K | ★ 202.7K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | $18.74 | $32.20 |
| Revenue Next Year | $18.00 | $4.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.75 | $4.20 |
| 52 Week High | $5.97 | $13.69 |
Technical Indicators
Market Signals| Indicator | REED | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 44.18 |
| Support Level | $3.50 | $6.25 |
| Resistance Level | $4.35 | $8.03 |
| Average True Range (ATR) | 0.42 | 0.60 |
| MACD | -0.07 | -0.09 |
| Stochastic Oscillator | 41.67 | 18.83 |
Price Performance
Historical ComparisonAbout REED Reed's Inc.
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.